BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PeptiCRAd-1 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PeptiCRAd-1\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05492682-2671@assetmemo.bio
DTSTAMP:20261121T005839Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:PeptiCRAd-1: Phase 1 readout est. (NCT05492682)
DESCRIPTION:PeptiCRAd-1\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: STA
 RT: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer\n
 Estimated primary completion: 30 April 2027. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/pepticrad-1#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT05492682
URL:https://assetmemo.bio/drug/pepticrad-1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
